Pancreatic Cancer Research

ResearcherInsermActive in the last 2 years

Elias Karam

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6603-3804; OpenAlex author ID A5090403194. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2025: 2 papers · 2026: 1 paper

Papers 3

  1. Laparoscopic left pancreatectomy is safe for the treatment of pancreatic ductal adenocarcinoma treated by chemoradiotherapy compared to open left pancreatectom… First author DOI 10.1007/s00464-026-12991-3↗
  2. Laparoscopic pancreatoduodenectomy is safe for the treatment of pancreatic ductal adenocarcinoma treated by chemoradiotherapy compared with open pancreatoduode… Co-author DOI 10.1016/j.surg.2024.09.041↗
  3. Laparoscopic compared with open pancreatoduodenectomy is safe for the treatment of pancreatic ductal adenocarcinoma treated by chemoradiotherapy. First author DOI 10.1016/j.surg.2025.109281↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Safi Dokmak · 3 shared papers, 2025–2026 · strength 0.89
  2. Alain Sauvanet Sauvanet · 3 shared papers, 2025–2026 · strength 0.89
  3. Mickaël Lesurtel · 3 shared papers, 2025–2026 · strength 0.89
  4. Ana Vlasceanu · 1 shared paper, 2026 · strength 0.32
  5. Louis de Mestier · 1 shared paper, 2026 · strength 0.32
  6. Vinciane Rebours · 1 shared paper, 2025 · strength 0.27
  7. Olivia Hentic Dhome · 1 shared paper, 2025 · strength 0.27

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.